Oscar Health, Inc. OSCR
We take great care to ensure that the data presented and summarized in this overview for Oscar Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSCR
View all-
Vanguard Group Inc Valley Forge, PA19MShares$293 Million0.0% of portfolio
-
Black Rock Inc. New York, NY14.2MShares$218 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY11.8MShares$182 Million3.94% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD11.4MShares$175 Million0.09% of portfolio
-
Jpmorgan Chase & CO New York, NY10.4MShares$160 Million0.01% of portfolio
-
Dragoneer Investment Group, LLC San Francisco, CA9.49MShares$146 Million2.78% of portfolio
-
Thrive Capital Management, LLC New York, NY6.34MShares$97.8 Million14.58% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY6.34MShares$97.6 Million0.99% of portfolio
-
State Street Corp Boston, MA5.92MShares$91.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.74MShares$73.1 Million0.01% of portfolio
Latest Institutional Activity in OSCR
Top Purchases
Top Sells
About OSCR
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Insider Transactions at OSCR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 05
2025
|
Victoria Baltrus Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,611
+4.6%
|
-
|
Mar 05
2025
|
Mario Schlosser President of Technology & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
172,269
+31.42%
|
-
|
Mar 05
2025
|
Adam Mc Ananey Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,409
+24.94%
|
-
|
Mar 05
2025
|
Janet Liang President, Oscar Insurance |
BUY
Grant, award, or other acquisition
|
Direct |
96,962
+33.28%
|
-
|
Mar 05
2025
|
Richard Scott Blackley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,426
+6.73%
|
-
|
Mar 01
2025
|
Victoria Baltrus Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,084
-2.37%
|
$71,176
$14.61 P/Share
|
Mar 01
2025
|
Richard Scott Blackley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,428
-1.66%
|
$313,992
$14.61 P/Share
|
Mar 01
2025
|
Mario Schlosser President of Technology & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,970
-3.77%
|
$111,580
$14.61 P/Share
|
Feb 24
2025
|
Adam Mc Ananey Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
123,376
+50.0%
|
-
|
Feb 24
2025
|
Janet Liang President, Oscar Insurance |
BUY
Grant, award, or other acquisition
|
Direct |
97,402
+50.0%
|
-
|
Feb 07
2025
|
Sid Sankaran |
BUY
Bona fide gift
|
Indirect |
295,687
+27.09%
|
-
|
Feb 07
2025
|
Sid Sankaran |
SELL
Bona fide gift
|
Direct |
295,687
-100.0%
|
-
|
Dec 06
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,939
-1.6%
|
$479,024
$16.23 P/Share
|
Dec 06
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
16,793
-1.9%
|
$268,688
$16.23 P/Share
|
Dec 05
2024
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+6.21%
|
-
|
Dec 05
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+6.53%
|
-
|
Dec 02
2024
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,078
-2.62%
|
$145,404
$18.28 P/Share
|
Dec 02
2024
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,279
-1.39%
|
$455,022
$18.28 P/Share
|
Dec 02
2024
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
26,895
-3.04%
|
$484,110
$18.28 P/Share
|
Dec 02
2024
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
19,157
-3.68%
|
$344,826
$18.28 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 719K shares |
---|---|
Exercise of conversion of derivative security | 3.02M shares |
Open market or private purchase | 3.18M shares |
Bona fide gift | 296K shares |
Payment of exercise price or tax liability | 35.5K shares |
---|---|
Open market or private sale | 754K shares |
Bona fide gift | 296K shares |